KEROS THERAPEUTICS
Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematologic and musculoskeletal disorders with a high unmet medical need. Keros is a leader in understanding the role of the Transforming Growth Factor-Beta, or TGF-ร, family of proteins, which are master regulators of red blood cell and platelet production as well as of the growth, repair and maintenance of muscle and bone. Keros' lead ... protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes and in patients with myelofibrosis. Keros' lead small molecule product candidate, KER-047, is being developed for the treatment of anemia resulting from elevated levels of hepcidin, the key regulator of iron absorption and recycling, as well as for the treatment of fibrodysplasia ossificans progressiva. Keros' third product candidate, KER-012, is being developed for the treatment of disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension.
KEROS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.kerostx.com
Total Employee:
11+
Status:
Active
Contact:
(617)513-8774
Total Funding:
90 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Amazon
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Baudax Bio
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
Clearside Biomedical
Clearside BioMedical isย an ophthalmic company that specializes inย the research, development, and commercialization of therapeutic products.
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Lixte Biotechnology Holdings
Lixte Biotechnology Holdings, a clinical-stage pharmaceutical company, focuses on discovering drugs for more effective cancer treatments.
OS Therapies
OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for Osteosarcoma.
Provention Bio
Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing and commercializing novel therapeutics.
Rarecells
Rarecells Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests.
Zymenex
Zymenex is a Scandinavian biopharmaceutical company focused on the development and commercialization of novel enzyme replacement therapies
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
OrbiMed
OrbiMed investment in Series C - Keros Therapeutics
Venrock
Venrock investment in Series C - Keros Therapeutics
Medison Pharma
Medison Pharma investment in Series C - Keros Therapeutics
Foresite Capital
Foresite Capital investment in Series C - Keros Therapeutics
Pontifax
Pontifax investment in Series C - Keros Therapeutics
Partners Innovation Fund
Partners Innovation Fund investment in Series C - Keros Therapeutics
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series C - Keros Therapeutics
Arkin Bio Ventures
Arkin Bio Ventures investment in Series C - Keros Therapeutics
Global health sciences venture fund
Global health sciences venture fund investment in Series C - Keros Therapeutics
Medison Pharma
Medison Pharma investment in Series B - Keros Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-01-31 | Keros Therapeutics Appoints Christopher Rovaldi as Chief Operating Officer |
Official Site Inspections
http://www.kerostx.com Semrush global rank: 1.05 M Semrush visits lastest month: 31.93 K
- Host name: 120.0.153.160.host.secureserver.net
- IP address: 160.153.0.120
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260